FDA, CDC Urge Halting Of Johnson & Johnson Vaccine Over ‘Extremely Rare’ Blood Clotting

While the CDC and FDA said blood clotting appears to be “extremely rare,” federal distribution of any Johnson & Johnson vaccine doses is expected to pause.

Leave a Reply